ArticleFrontiers in endocrinology2026
Fulminant pheochromocytoma crisis triggered by glucocorticoids: ultra-early adrenalectomy under ECMELLA support.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pheochromocytoma crisis is a rare but life-threatening condition that may present with refractory cardiogenic shock and malignant arrhythmias. In this setting, the patient is often too unstable for surgery, although tumor removal remains the only definitive treatment. We report the case of a 57-year-old woman with an adrenal mass who developed a fulminant catecholaminergic crisis after high-dose glucocorticoid administration for contrast allergy prophylaxis. She presented with severe metabolic acidosis (pH 6.98, lactate 14.8 mmol/L), flash pulmonary edema, and acute catecholamine-induced cardiomyopathy with a Takotsubo pattern (LVEF 25%). Initial support with Impella CP was insufficient due to electrical storm and hypermetabolic state. Mechanical support was escalated to combined veno-arterial extracorporeal membrane oxygenation (VA-ECMO) and Impella (ECMELLA). Because of persistent instability, ultra-early robot-assisted adrenalectomy was performed under full mechanical support. The patient was successfully weaned from Impella on postoperative day (POD) 1 and from ECMO on POD5, with progressive cardiac recovery (LVEF 35% at POD14). To our knowledge, this is one of the first (or the first) reported cases of robot-assisted adrenalectomy performed under full ECMELLA support without prior durable hemodynamic stabilization, suggesting a potential role for this strategy in highly selected patients with refractory pheochromocytoma crisis. It also underscores glucocorticoids as a critical and underrecognized trigger.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.